ArticleIrish journal of medical science2023
Impact factor JUMPS after the 2020 COVID-19 pandemic: a retrospective study in Dermatology journals.
Article in Irish journal of medical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Resilience and Recalibration of Bibliometric Indicators in Neurosciences and Neuropharmacology Journals After COVID-19: A Longitudinal Rate of Change Analysis Using Mixed-Effects Models.Current neuropharmacology · 2026Article
- The impact of COVID-19 on global health journals: an analysis of impact factor and publication trends.BMJ global health · 2023Article
- Looking Back at 2022 and ahead to 2023 for theKorean journal of radiology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe term "JUMPS" was used to describe the impact factor (IF) in an article published in PubMed in 2021, representing an increase of more than 40% of IF.
aimsIn this study, we aimed to compare the growth rate of IF JUMPS in Dermatology in the last 5 years, and particularly the effect of the 2020 COVID-19 pandemic.
methodsThis study evaluated the growth rate (JUMP) in IF from 2016 to 2020. We used the Friedman and Wilcoxon signed ranks tests. We classified JUMPS in negative growth rate; Q1 to Q4 quartiles; and journals with > 100%. A 76-100% growth rate was observed in five (7%) journals, and twelve journals (17%) depicted a 51-75% percentage of change.
resultsSeveral journals in the Dermatology category increased their IF by 50%. Repeated measures analyses showed a significant difference (p < .001).
conclusionAlthough we found journals with growth rates in the four quartiles, no journals depicted negative growth rates nor > 100% growth. Knowing the growing trends in this category might supplement the assessment of target journals for authors looking to submit their works.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.